Avantor® Participates in BioProcess International 2024 Conference Scientific Program and Exhibition
Avantor, Inc. (NYSE: AVTR) announced its participation in the BioProcess International 2024 conference, scheduled for September 23-26 in Boston. The company will deliver multiple scientific presentations and exhibit at the event, which is expected to attract over 3,200 biopharmaceutical professionals from 40+ countries.
Key presentations include:
- A novel approach to AAV harvest and purification process optimization
- Keynote address on adapting to changing molecules and regulatory expectations
- Viral gene therapy manufacturing at scale
Avantor will also showcase its Magnetic Mixing Systems portfolio on the exhibit floor, focusing on solutions for production scale-up and downstream process optimization. The company's presence at the conference underscores its commitment to delivering innovative solutions for biopharmaceutical development and production challenges.
Avantor, Inc. (NYSE: AVTR) ha annunciato la propria partecipazione alla conferenza BioProcess International 2024, programmata dal 23 al 26 settembre a Boston. L'azienda presenterà diverse comunicazioni scientifiche ed esporrà durante l'evento, che si prevede attirerà oltre 3.200 professionisti dell'industria biofarmaceutica provenienti da oltre 40 paesi.
Le presentazioni chiave includono:
- Un nuovo approccio all'ottimizzazione del processo di raccolta e purificazione di AAV
- Discorso principale sull'adattamento a molecole in evoluzione e aspettative normative
- Produzione su larga scala di terapia genica virale
Avantor mostrerà anche il proprio portafoglio di Magnetic Mixing Systems nell'area espositiva, concentrandosi su soluzioni per l'ottimizzazione della produzione e del processo di downstream. La presenza dell'azienda alla conferenza sottolinea il suo impegno a fornire soluzioni innovative per le sfide dello sviluppo e della produzione biofarmaceutica.
Avantor, Inc. (NYSE: AVTR) anunció su participación en la conferencia BioProcess International 2024, programada del 23 al 26 de septiembre en Boston. La compañía realizará múltiples presentaciones científicas y tendrá un stand en el evento, que se espera atraiga a más de 3,200 profesionales biofarmacéuticos de más de 40 países.
Las presentaciones clave incluirán:
- Un enfoque novedoso para la optimización del proceso de cosecha y purificación de AAV
- Discurso principal sobre la adaptación a moléculas cambiantes y expectativas regulatorias
- Fabricación de terapia génica viral a gran escala
Avantor también exhibirá su portafolio de Sistemas de Mezcla Magnética en el piso de exposición, enfocándose en soluciones para la escalabilidad de la producción y la optimización del proceso downstream. La presencia de la compañía en la conferencia subraya su compromiso de ofrecer soluciones innovadoras para los desafíos del desarrollo y la producción biofarmacéutica.
Avantor, Inc. (NYSE: AVTR)는 보스턴에서 9월 23일부터 26일까지 열리는 BioProcess International 2024 회의에 참여한다고 발표했습니다. 이 회사는 여러 과학 발표를 진행하고 행사에 전시할 예정이며, 40개국 이상에서 3,200명 이상의 생명공학 전문가를 유치할 것으로 예상됩니다.
주요 발표 내용은 다음과 같습니다:
- AAV 수확 및 정화 과정 최적화를 위한 새로운 접근법
- 변화하는 분자 및 규제 기대에 적응하는 방법에 대한 기조연설
- 규모에 맞춘 바이러스 유전자 치료 제조
Avantor는 전시장에서 자기 혼합 시스템 포트폴리오를 선보일 예정이며, 생산 규모 확대 및 다운스트림 공정 최적화를 위한 솔루션에 중점을 둡니다. 이 회사의 회의 참여는 생물 의약품 개발 및 생산 문제에 대한 혁신적인 솔루션 제공을 위한 의지를 강조합니다.
Avantor, Inc. (NYSE: AVTR) a annoncé sa participation à la conférence BioProcess International 2024, prévue du 23 au 26 septembre à Boston. L'entreprise fera plusieurs présentations scientifiques et exposera lors de l'événement, qui devrait attirer plus de 3 200 professionnels de la biopharmacie venant de plus de 40 pays.
Parmi les présentations clés, on trouve :
- Une nouvelle approche pour l'optimisation du processus de récolte et de purification des AAV
- Discours d'ouverture sur l'adaptation aux molécules changeantes et aux attentes réglementaires
- Fabrication de thérapies géniques virales à grande échelle
Avantor mettra également en avant son portefeuille de Systèmes de Mélange Magnétique sur le stand d'exposition, se concentrant sur des solutions pour l'optimisation de la production à grande échelle et des processus en aval. La présence de l'entreprise à la conférence souligne son engagement à fournir des solutions innovantes pour les défis du développement et de la production biopharmaceutique.
Avantor, Inc. (NYSE: AVTR) gab seine Teilnahme an der BioProcess International 2024 Konferenz bekannt, die vom 23. bis 26. September in Boston stattfinden wird. Das Unternehmen wird mehrere wissenschaftliche Präsentationen halten und auf der Veranstaltung ausstellen, die voraussichtlich über 3.200 Fachleute aus der biopharmazeutischen Industrie aus mehr als 40 Ländern anziehen wird.
Zu den Hauptpräsentationen gehören:
- Ein neuer Ansatz zur Optimierung des Ernte- und Reinigungsprozesses von AAV
- Hauptvortrag über die Anpassung an sich verändernde Moleküle und regulatorische Erwartungen
- Viralgen-Therapie-Produktion im großen Maßstab
Avantor wird auch sein Portfolio der Magnetischen Mischsysteme auf der Ausstellungsfläche präsentieren und dabei Lösungen zur Skalierung der Produktion und Optimierung der downstream Prozesse in den Fokus rücken. Die Präsenz des Unternehmens auf der Konferenz unterstreicht sein Engagement, innovative Lösungen für die Herausforderungen der biopharmazeutischen Entwicklung und Produktion zu liefern.
- Avantor is presenting multiple scientific sessions at a major industry conference, demonstrating thought leadership
- The company is showcasing its Magnetic Mixing Systems portfolio, highlighting product innovation
- Participation in the conference provides networking opportunities with potential customers
- None.
Avantor's scientific presentations at BioProcess International 2024 include:
Presenter - Jungmin Oh, Ph.D., Senior Manager, New Product Development
Session Title - A novel approach to optimization of AAV harvest and purification process
Date and Time - September 25, 12:30 pm
Presenter - Nandu Deorkar, Ph.D., Senior Vice President, Biopharma Production Research & Development
Session Title - Keynote Address: Adapting to Changing Molecules and Regulatory Expectations
Date and Time – September 26, 10:00 am
Presenter - Jerry Keybl, Ph.D., Senior Vice President, Biopharma Products & Strategy
Session Title - Viral Gene Therapy Manufacturing at Scale – Assembling Solutions to Drive Industrialization
Date and Time - September 26, 12:15 pm
"Avantor's significant presence at BioProcess International 2024 is a testament to our reputation for delivering leading solutions across the spectrum of biopharmaceutical development and production," said Benoit Gourdier, Executive Vice President and Head of Avantor's Bioscience Production Segment. "We look forward to engaging with customers and attendees in
In addition to its multiple scientific presentations, Avantor will also have a strong presence on the exhibit floor, focusing on its industry leading solutions for production scale up and downstream process optimization. Avantor will present its Magnetic Mixing Systems portfolio, which ranges from 50 to 1500 liters, and now includes a newly launched tabletop mixer for single-use mixing needs. These scalable Magnetic Mixing Systems are designed to maximize mixing efficiency with low shear rates, ensuring consistent homogeneity and minimizing risk to product quality. Avantor's experienced team of engineers can also help design specialized solutions tailored to customers unique bioprocessing mixing needs.
About Avantor
Avantor® is a leading life science tools company and global provider of mission-critical products and services to the life sciences and advanced technology industries. We work side-by-side with customers at every step of the scientific journey to enable breakthroughs in medicine, healthcare, and technology. Our portfolio is used in virtually every stage of the most important research, development and production activities at more than 300,000 customer locations in 180 countries. For more information, visit avantorsciences.com and find us on LinkedIn, X (Twitter) and Facebook.
Global Media Contact
Eric Van Zanten
Head of External Communications
Avantor
610-529-6219
Eric.VanZanten@avantorsciences.com
Investor Relations Contact
Christina Jones
Vice President, Investor Relations
Avantor
805-617-5297
Christina.Jones@avantorsciences.com
View original content:https://www.prnewswire.com/news-releases/avantor-participates-in-bioprocess-international-2024-conference-scientific-program-and-exhibition-302254597.html
SOURCE Avantor and Financial News
FAQ
What is Avantor's (AVTR) role in BioProcess International 2024?
When and where is BioProcess International 2024 taking place?
What products will Avantor (AVTR) be showcasing at BioProcess International 2024?
Who are the key presenters from Avantor (AVTR) at BioProcess International 2024?
